2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine

2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine

• CAS Number: 2072145-79-8
• UNSPSC Description: 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-5-methoxy uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
• Target Antigen: Nucleoside Antimetabolite/Analog
• Type: Oligonucleotides
• Related Pathways: Cell Cycle/DNA Damage
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/2-3-5-tri-o-benzoyl-2-β-c-methyl-5-methoxy-uridine.html
• Solubility: 10 mM in DMSO
• Smiles: C[C@@]1(OC(C2=CC=CC=C2)=O)[C@H](OC(C3=CC=CC=C3)=O)[C@@H](COC(C4=CC=CC=C4)=O)O[C@H]1N5C(NC(C(OC)=C5)=O)=O
• Molecular Weight: 600.57
• References & Citations: [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported